| Trial ID: | L0913 |
| Source ID: | IRCT2013052313427N1
|
| Associated Drug: |
DHA
|
| Title: |
The efficacy of Omega3 in treatment of Non-Alcoholic Fatty Liver Disease
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Fatty (change of) liver. <br>Nonalcoholic fatty liver disease (NAFLD);Nonalcoholic fatty liver disease (NAFLD)
|
| Interventions: |
Intervention group get Omega3 2 gram per day (cap 1000mg (EPA 180: DHA 120)) for 3 months with other treatment have given to control group. Control group: increase activity, diet, Vit E, Liver support and metformin..;Treatment - Drugs;Intervention group g
|
| Outcome Measures: |
Fatty liver. Timepoint: Before intervention, 3 months after intervention. Method of measurement: AST, ALT(liver enzymes).nan
|
| Sponsor/Collaborators: |
Fasa University of Medical Sciences
|
| Gender: |
All
|
| Age: |
18 yearsno limit
|
| Phases: |
Not applicable
|
| Enrollment: |
50
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.
|
| Start Date: |
22/09/2013
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/13283
|
